Exponent, Inc. (EXPO)
NASDAQ: EXPO · Real-Time Price · USD
72.65
+1.72 (2.42%)
At close: Aug 13, 2025, 4:00 PM
73.05
+0.40 (0.55%)
After-hours: Aug 13, 2025, 5:47 PM EDT

Revenue by Product

Fiscal year is February - January.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Jan '25 Dec '23 Dec '22 Dec '21 Jan '21 2012 - 2019
Engineering and Other Scientific
469.54M
Log In
Log In
Log In
Log In
Upgrade
Engineering and Other Scientific Growth
4.32%
Log In
Log In
Log In
Log In
Upgrade
Environmental and Health
88.97M
Log In
Log In
Log In
Log In
Upgrade
Environmental and Health Growth
-0.86%
Log In
Log In
Log In
Log In
Upgrade
Other
-40.02M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
24.45%
Log In
Log In
Log In
Log In
Upgrade
Other
-40.02M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
24.45%
Log In
Log In
Log In
Log In
Upgrade

Capex by Product

Fiscal year is February - January.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Jan '25 Dec '23 Dec '22 Dec '21 Jan '21 2012 - 2019
Other
-438.00K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-183.45%
Log In
Log In
Log In
Log In
Upgrade
Engineering and Other Scientific Capital Expenditures
3.26M
Log In
Log In
Log In
Log In
Upgrade
Engineering and Other Scientific Capital Expenditures Growth
-34.19%
Log In
Log In
Log In
Log In
Upgrade
Environmental and Health Capital Expenditures
77.00K
Log In
Log In
Log In
Log In
Upgrade
Environmental and Health Capital Expenditures Growth
-13.33%
Log In
Log In
Log In
Log In
Upgrade
Corporate Capital Expenditures
4.04M
Log In
Log In
Log In
Log In
Upgrade
Corporate Capital Expenditures Growth
311.47%
Log In
Log In
Log In
Log In
Upgrade
Other
-438.00K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-183.45%
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is February - January.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Jan '25 Dec '23 Dec '22 Dec '21 Jan '21 2012 - 2019
Engineering and Other Scientific Operating Income
164.88M
Log In
Log In
Log In
Log In
Upgrade
Engineering and Other Scientific Operating Income Growth
-2.10%
Log In
Log In
Log In
Log In
Upgrade
Environmental and Health Operating Income
30.00M
Log In
Log In
Log In
Log In
Upgrade
Environmental and Health Operating Income Growth
4.73%
Log In
Log In
Log In
Log In
Upgrade
Corporate Operating Income
-75.32M
Log In
Log In
Log In
Log In
Upgrade
Corporate Operating Income Growth
2.70%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is February - January.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Jan '25 Dec '23 Dec '22 Dec '21 Jan '21 2012 - 2019
United States
493.07M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-
Log In
Log In
Log In
Log In
Upgrade
Foreign Countries
65.45M
Log In
Log In
Log In
Log In
Upgrade
Foreign Countries Growth
-
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is February - January.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Jan '25 Dec '23 Dec '22 Dec '21 Jan '21 2012 - 2019
Technical Full-Time Equivalent Employees
967.00
Log In
Log In
Log In
Log In
Upgrade
Technical Full-Time Equivalent Employees Growth
-1.74%
Log In
Log In
Log In
Log In
Upgrade